Equity in Access Research Grants
Forecasted
Equity in Access Research Grants support researchers studying insurance-related barriers to cancer care for people with blood cancer, to identify solutions that improve access through policy, practice, or programs.
Browse similar grants
Funder: Leukemia & Lymphoma Society (now Blood Cancer United)
Due Dates (Anticipated): February 2027 (Invited full proposals) | September 2027 (Letters of Intent)
Funding Amounts: Nearly $5 million awarded across five-year grants under a previous request for proposals; current award amounts are not listed
Summary: Funds research on insurance-related barriers to equitable cancer care for people diagnosed with blood cancer.
Key Information: Full proposals are accepted by invitation after Letter of Intent review.
Description
Blood Cancer United, formerly the Leukemia & Lymphoma Society, runs the Equity in Access Research Program to improve access to care for people diagnosed with blood cancer and for survivors. The program seeks evidence that can guide policy reform, healthcare practice, and program delivery while reducing barriers linked to social, economic, and environmental disadvantages.
The current request for proposals focuses on how health insurance affects access to cancer care. It seeks research examining barriers associated with insurance status, type, design, and policy changes, and identifying actionable solutions to address them.
